Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.335
-0.095 (-2.77%)
At close: Apr 28, 2026, 4:00 PM EDT
3.260
-0.075 (-2.25%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $7.48 million as of April 28, 2026. Its market cap has increased by 7.97% in one year.
Market Cap
7.48M
Enterprise Value
-941.35K
1-Year Change
7.97%
Ranking
Category
Stock Price
$3.34
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $7.48M, a decrease of -84.40%. That is a compound annual growth rate of -32.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 7.69M | 50.93% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 8.06M |
| BioAtla | 7.87M |
| Creative Medical Technology Holdings | 7.86M |
| PharmaCyte Biotech | 7.77M |
| Acurx Pharmaceuticals | 7.71M |
| GridAI Technologies | 7.70M |
| Processa Pharmaceuticals | 7.64M |
| TransCode Therapeutics | 7.61M |